Objective: The prime objective was to determine the impact of HIV-associated neurocognitive disorders on activities of daily living and its association with depression. Material & Methods: A prospective cohort study was conducted in '80' HIV positive patients, registered at ART Centre of PBM and AG Hospital, Bikaner. A test battery comprising of three scales was used i.e. International HIV Dementia Scale (IHDS), Activities of Daily Living(ADL) scale and PRIME-MD Patient Health Questionnaire(PHQ-9) to diagnose cognitive dysfunction, dependence in ADL and depression respectively. Results: The 32.50% (n=26) of the patients were diagnosed to have cognitive dysfunction (IHDS Score<10) while remaining 67.50% (n=54) of the patients were normal (IHDS Score>10). Out of these cognitively impaired patients, n=2 patients were found to be dependent in >2 ADL while remaining patients were able to perform their ADL independently. No significant association was found between depression and cognitive dysfunction. Conclusion: Patients having score of <10 on IHDS were further classified on the basis of dependence in ADL. The patients having high degree of depressive symptoms were more likely to have cognitive dysfunction but the results were not significant. 
INTRODUCTION
The HIV infection has been declared as one of the worst pandemic, which is often associated with neurocognitive and psychological impairment. The neurocognitive complications associated with HIV have recently been characterized as HIV-associated neurocognitive disorders (HAND). HAND defines three categories of dysfunction: asymptomatic neurocognitive impairment (ANI), mild neurocognitive disorder (MND) and HIV-associated dementia (HAD). 1 Since the introduction of highly active antiretroviral therapy (HAART), the incidence of severe forms of HAND has declined significantly, whereas the prevalence of the milder forms has increased. 2, 3 There is clinical significance of identifying the milder forms of HAND, as they can have a significant impact on the lives of people living with HIV. They have been shown to interfere with medication adherence, workplace performance, driving and ability to carry out tasks independently. 4, 5, 6 Major depressive disorder (MDD) is the most common neuropsychiatric symptom associated with HIV. MDD may share similar pathological features (e.g. frontostriatal circuits) to HIV infection and has been indepen dently associated with subtle cognitive decline in areas including attention, psychomotor speed, learning and memory, and executive functioning. Despite the similar underlying neural abnormalities, most studies have failed to find synergistic effects of depression and HIV infection on cognition. 7 The neuropsychological impairment among HIV-positive patients remains largely unrecognized because it is not routinely screened for, despite this recommendation in HIV treatment guidelines. Early and periodical neuro psychological screening of HIV positive asymptomatic individuals is a must in future to spot the neurocognitive deficits at an early stage. 8 
MATERIAL AND METHODS

Study design
This was a prospective cohort study undertaken between Oct.2011 and Sept.2012 in '80' HIV/AIDS patients undergoing antiretroviral treatment. All the participants were registered with the ART Centre of PBM and AG Hospital, Bikaner, Rajasthan, India.
Ethical considerations
The study obtained ethical approval from the Ethical Committee of Sardar Patel Medical College, Bikaner. Study participants were invited to consent after being provided with adequate information about the study. To be eligible for inclusion in this study, following criteria were used for the participants- 
Impact of HIV associated neurocognitive disorders on activities of daily living and its association with depression in outdoor patients undergoing HAART
Seriously ill patients, pregnant women, patients having severe psychiatric disorder or any substance abuse were excluded from the study.
Data collection tools
All the participants underwent neurocognitive examination, assessment of depression and activities of daily living. The tools included a sociodemographic questionnaire, the International HIV Dementia Scale (IHDS), Activities of Daily Living (ADL) scale and PRIME-MD Patient Health Questionnaire (PHQ-9). According to modified updated American Academy of Neurology (AAN) criteria, patients with HAND are classified on the basis of neurocognitive impairment and severity of dependence in activities of daily living (ADL). To assess neurocognitive impairment we used IHDS while dependence in ADL was assessed by ADL scale.
International HIV Dementia Scale
The IHDS is a screening measure of neurocognitive impairment that assesses for memory impairment, motor and psychomotor speed. It can be used in a clinic setting, does not require one to be proficient in English and is brief and inexpensive. Here a cut-off score of <10 was taken to screen dementia cases. 10, 11 It is a '14-item scale' that measures physical self-maintenance activities and instrumental activities of daily living. Patients were classified as ' ADL dependent' if they reported decline in two or more ADL.
PRIME-MD Patient Health Questionnaire (PHQ-9) for endogenous depression
The PHQ-9 follows the Diagnostic and Statistical Manual-IV (DSM-IV) Criteria for screening patients for current depression. If 5 or more of the 9 symptoms are present and one of the symptoms is sadness/ hopelessness or anhedonia, then a diagnosis of major depressive disorder is supported.
12,13
Statistical Analysis
Means and Standard Deviations (SD) were calculated for continuous variables. To analyse the association between the various factors and cognitive dysfunction, chi square test was employed. The p value of less (51) 25 (31) 10 (13) 4(5) 
RESULTS
Of the '80' study participants, 45 were males (56%) and 35 were females (44%). The socio-demographic characteristics of the participants are presented in Table 1 . In present study, using a cut-off score of 10 or less on the IHDS, patients were classified as having cognitive dysfunction and normal cognitive function. Out of total '80' HIV-positive patients, 26 patients (32.50%) had scored <10 on IHDS while remaining 54 patients (67.50%) scored >10 (See Figure 1) .
Further classification of cognitively impaired patients was done on the basis of dependence in ADL. The 2.50% (n=2) of the patients were found to be dependent in >2 ADL while the 97.50% (n=78) of the patients were able to perform their ADL independently i.e. ADL independent (See Figure 2) .
Classification of HAND according to modified updated American Academy of Neurology (AAN) criteria
Patients who were found to be dependent in ADL and had scored <10 on the IHDS were classified under mild neurocognitive disorder (MND) category of HAND whereas the patients who were ADL independent and had a score of <10 on IHDS were categorised under asymptomatic One of the factors discussed in relation to cognitive dysfunction in HIV positive individuals is co-morbid depression. In concordance with previous studies 18,7 the present study also did not observed significant association between depression and cognitive dysfunction.
CONCLUSION
To conclude, the neuropsychological impairment among HIV positive patients on ARV therapy leads to a reduction in the quality of life and the patients having high degree of depressive symptoms are more likely to have cognitive dysfunction. It is an important challenge due to the high prevalence of HAND and its concomitant consequences in relation to morbidity and mortality. The presence of mild neurocognitive disorder in HIV is predictive of HAD, the most severe form of HAND. Therefore, early and periodical neuropsychological screening of HIV positive individuals is a must in future, to spot the neurocognitive deficits at an early stage.
